Literature DB >> 6445850

Gastric inhibitory polypeptide (GIP) is not the primary mediator of the enterogastrone action of fat in the dog.

T Yamagishi, H T Debas.   

Abstract

We compared the inhibition of food-stimulated gastric acid secretion and changes in serum concentrations of immunoreactive gastric inhibitory polypeptide and gastrin caused by: (a) duodenal perfusion of oleic acid, and (b) intravenous infusion of pure, natural, porcine gastric inhibitory, polypeptide in dogs with gastric fistula and pancreatic fistula. A rate of duodenal perfusion of oleic acid (12 ml/hr) which gave near maximal pancreatic protein response was chosen. This dose of oleic acid caused complete suppression of acid response to a meal of liver extract (300 ml of a 15% solution) while elevating serum immunoreactive gastric inhibitory polypeptide modestly. By contrast, intravenous administration of gastric inhibitory polypeptide that raised serum immunoreactive gastric inhibitory polypeptide several fold caused only 40% inhibition of acid response to the same meal. Other effects of duodenal perfusion of oleic acid were exaggeration of pancreatic protein secretion and significant inhibition of gastrin release in response to the meal. Exogenous administration of gastric inhibitory polypeptide, on the other hand, was without significant effect on these responses. These results suggest that, in the innervated dog stomach, the enterogastrone action of fat is not primarily mediated by gastric inhibitory polypeptide.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6445850

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  High-fat diet in a short bowel syndrome. Intestinal absorption and gastroenteropancreatic hormone responses.

Authors:  V Simko; A M McCarroll; S Goodman; R E Weesner; R E Kelley
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

2.  Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat.

Authors:  C C Tseng; L A Jarboe; S B Landau; E K Williams; M M Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

3.  Comparison of gastric inhibitory polypeptide and intraduodenal or intravenous fat on gastric acid secretion from vagally innervated and denervated canine stomach.

Authors:  S J Konturek; J Konturek; M Cieszkowski; R Ebert; W Creutzfeldt
Journal:  Dig Dis Sci       Date:  1986-01       Impact factor: 3.199

4.  Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man.

Authors:  V Maxwell; A Shulkes; J C Brown; T E Solomon; J H Walsh; M I Grossman
Journal:  Dig Dis Sci       Date:  1980-02       Impact factor: 3.199

5.  Inhibition of gastric secretion by fat and hypertonic glucose in the dog: role of gastric inhibitory peptide.

Authors:  W Creutzfeldt; R Ebert; U Finke; S J Konturek; N Kwiecień; T Radecki
Journal:  J Physiol       Date:  1983-01       Impact factor: 5.182

Review 6.  Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective.

Authors:  Joanna Michałowska; Ewa Miller-Kasprzak; Paweł Bogdański
Journal:  Nutrients       Date:  2021-01-25       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.